Why Kura Oncology, Inc. (KURA) stock rose 8.1% intraday on Wednesday, November 11, 2026
Kura Oncology, Inc. (KURA) traded at $8.18 as of 9:51 AM ET, up 8.06% on Wednesday, November 11, 2026, on volume of 506,205 shares (0.2× its 3-month average); market value about $700.0M, according to Nexqual market data (nexqual.com/moves/2026-11-11/KURA).
KURA was among the stocks moving 5% or more in an earlier update that day; by the close it was no longer moving that much.
What happened: primary sources
Events Nexqual found for KURA on Wednesday, November 11, 2026 or the trading day before (November 10, 2026), each linked to its primary source:
- Nov 10, 2026: Reported Q3 2026 results: EPS −$0.78 vs consensus −$0.81 (beat), revenue $22.8M vs consensus $23.9M (miss). Guidance: Kura updated its 2026 collaboration revenue guidance to $40 million to $45 million and maintains 2027 and 2028 guidance of $90 million to $110 million each. source
- Nov 11, 2026: One of 3 Biotechnology stocks among the day's biggest gainers (PEPG, CAPR, KURA), with no comparable group among the biggest losers
These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.
More on KURA
KURA stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Earnings report: KURA results, November 10, 2026. Other big moves that day: November 11, 2026.
Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 18, 2026 at 20:53 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 18, 2026 at 20:53 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt